Difference between revisions of "Perfusion, Diffusion and Flow-MRI Biomarker Ctte"
Jump to navigation
Jump to search
| Line 15: | Line 15: | ||
'''''[[PDF BC Call Summaries Archive]]''''' | '''''[[PDF BC Call Summaries Archive]]''''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
Revision as of 22:00, 2 October 2018
- Co-chairs: Michael Boss, PhD; John Kirsch, PhD; Daniel Barboriak, MD
- Secretary: Susan Stanfa
Recent PDF-MRI Meetings
Approved call summaries:
ADC Phantom Materials
QIBA ADC Phantom Preparation Instructions 03-March-2017
QIBA-IMI ADC Phantom Design Update 07-August-2013
ADC Phantom Design- Feedback Request 14-March-2013
Reference Materials
- QIBA Profile Compliance - Clinical Environment 30-August-2013
- PDF-MRI Technical Committee Report to the Steering Committee - 01.31.2013
- MR Phantom Development / Data Efforts - May 2010 QIBA Meeting Breakout Session
- Siemens-QIBA Protocol -- July 1, 2009 -- Dr David Purdy
- MDACC/U Chicago Phantom Data Analysis Comparison -- Sept 2, 2009 -- Dr Edward Jackson